STAAR Surgical Company: stock overview

STAANASDAQHealthcare · Ophthalmic Goods

Price

$26.39

November 13, 2026Market cap $1.3B

DCF calculator

What Ploutos Investor adds for STAAR Surgical

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

STAAR Surgical had revenue of $328M over the last 12 months and net income of $530.0K, a net margin of 0.2%. Revenue grew by 7.9% a year on average over the last 5 years. At $26.39 the shares trade at a P/E of 2,465.4. It holds more cash than debt, by $206M. It pays no dividend.

From its SEC filings (latest fiscal year to January 2, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$1.3B
49.51M shares
P/E
2,465.4
Revenue, 12 months
$328M
+7.9% a year over 5 years
Net margin
0.2%
FY2025: -33.6%, above 19% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2023–FY2025 fiscal years

-13.8% a year over 2 years

  • FY2025Jan 2, 202610-K
    Revenue$239M
  • FY2024Dec 27, 202410-K
    Revenue$314M
  • FY2023Dec 29, 202310-K
    Revenue$322M

Fiscal years in figures

STAA's revenue, profit, cash flow and dividend with each year-end price, from FY2009 to FY2022, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $1.2B
$1.3B
Enterprise value 
$1.1B
P/E 
2,465.4
EV / EBIT 
1,569.5
EV / Revenue 
3.4
P/B 3-year median: 3.4
3.5
FCF yield 3-year median: -0.6%
1.4%
Earnings yield 3-year median: -1.7%
0.0%

Profitability

Gross margin 
73.6%
Operating margin 
0.2%
Net margin 3-year median: -6.4%
0.2%
ROIC 
0.2%
ROIC, 5-year average 
0.5%
ROE 
0.2%

Growth

Revenue, yearly change 
-23.7%
EPS, yearly change 
–
FCF, yearly change 
–
Revenue, average a year 
+7.9%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$206M
Total debt 
$34M
Of which operating leases 
$34M
Net cash 
$206M
Net debt / EBITDA 
-22.9x
Interest cover 
–
Current ratio 
4.68

Balance sheet of October 2, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
0.49%
Total returned 
0.49%
Shares, yearly change 
+0.4%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

76.2%

Above 87% of the 161 companies in its industry, and 92% of all.

Operating margin

-38.3%

Above 17% of the 186 companies in its industry, and 9% of all.

Net margin

-33.6%

Above 19% of the 189 companies in its industry, and 9% of all.

ROE

-23.4%

Above 24% of the 174 companies in its industry, and 13% of all.

ROA

-17.8%

Above 21% of the 190 companies in its industry, and 10% of all.

Revenue growth

-23.7%

Above 2% of the 186 companies in its industry, and 3% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
STAAR SURGICAL CO
CIK
718937
Exchange
NASDAQ
Industry (SIC)
3851 · Ophthalmic Goods
Fiscal year ends
January 2
Latest annual report
January 2, 2026
Reporting currency
USD
Shares
49.51M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do STAAR Surgical's filings show?

These are STAAR Surgical's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about STAA

Didn't find what you were looking for?

Ask us
What is STAA's market cap?

STAAR Surgical Company's market cap is $1.3B, at a price of $26.39 on November 13, 2026 and 49.51M shares.

What is STAA's P/E?

STAA's P/E is 2,465.4, on earnings per share of $0.01 over the last 12 months.

How much revenue does STAA have?

STAAR Surgical had revenue of $328M over the last 12 months. Over the last 5 years it changed by +7.9% a year on average.

Does STAA pay a dividend?

No. STAAR Surgical paid no regular dividend over the last 12 months.

Where do the figures come from?

From STAAR Surgical Company's SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.